We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$894M
AUM Growth
+$54.4M
Cap. Flow
+$11.9M
Cap. Flow %
1.33%
Top 10 Hldgs %
28.23%
Holding
350
New
47
Increased
126
Reduced
110
Closed
18

Top Buys

Rank Stock Value
1
APH icon
Amphenol
APH
+$6.69M
2
ACN icon
Accenture
ACN
+$4.77M
3
G icon
Genpact
G
+$3.22M
4
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$3.04M
5
KLAC icon
KLA
KLAC
+$2.23M

Top Sells

Rank Stock Value
1
OKE icon
Oneok
OKE
+$4.03M
2
JNJ icon
Johnson & Johnson
JNJ
+$3.23M
3
UNH icon
UnitedHealth
UNH
+$2.21M
4
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$1.77M
5
AZN icon
AstraZeneca
AZN
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Healthcare 11.58%
3 Financials 10.42%
4 Consumer Staples 8.55%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
151
Allstate
ALL
$68.1B
$408K 0.05%
3,745
-1,146
-23% -$130K
MUSA icon
152
Murphy USA
MUSA
$10.7B
$396K 0.04%
1,273
+77
+6% +$21.6K
GE icon
153
GE Aerospace
GE
$396B
$390K 0.04%
4,453
-49
-1% -$3.97K
USPH icon
154
US Physical Therapy
USPH
$1.18B
$388K 0.04%
3,200
+877
+38% +$94.6K
IBM icon
155
IBM
IBM
$222B
$377K 0.04%
2,815
-125
-4% -$16.1K
NOC icon
156
Northrop Grumman
NOC
$79.2B
$373K 0.04%
818
+5
+0.6% +$2.27K
SGEN
157
DELISTED
Seagen Inc. Common Stock
SGEN
$368K 0.04%
1,914
-854
-31% -$170K
EPAC icon
158
Enerpac Tool Group
EPAC
$1.89B
$365K 0.04%
13,524
UPS icon
159
United Parcel Service
UPS
$91.5B
$363K 0.04%
2,028
+5
+0.2% +$888
GILD icon
160
Gilead Sciences
GILD
$164B
$362K 0.04%
4,701
+102
+2% +$8.13K
SHW icon
161
Sherwin-Williams
SHW
$89.7B
$360K 0.04%
+1,356
New +$319K
IWM icon
162
iShares Russell 2000 ETF
IWM
$82.5B
$357K 0.04%
1,906
BCO icon
163
Brink's
BCO
$4.77B
$356K 0.04%
5,249
WEC icon
164
WEC Energy
WEC
$35.3B
$355K 0.04%
4,019
TKR icon
165
Timken Company
TKR
$9.13B
$347K 0.04%
3,792
-458
-11% -$36.1K
NBTB icon
166
NBT Bancorp
NBTB
$2.77B
$345K 0.04%
10,832
GWW icon
167
W.W. Grainger
GWW
$60.7B
$335K 0.04%
425
FXG icon
168
First Trust Consumer Staples AlphaDEX Fund
FXG
$228M
$331K 0.04%
5,282
-2,240
-30% -$140K
NGVT icon
169
Ingevity
NGVT
$2.65B
$329K 0.04%
5,661
+947
+20% +$56.8K
FNDX icon
170
Schwab Fundamental US Large Company Index ETF
FNDX
$27.2B
$329K 0.04%
17,145
-1,422
-8% -$26.3K
LLY icon
171
Eli Lilly
LLY
$1.04T
$328K 0.04%
699
-57
-8% -$23.9K
BRK.B icon
172
Berkshire Hathaway Class B
BRK.B
$1.12T
$326K 0.04%
957
MGPI icon
173
MGP Ingredients
MGPI
$379M
$326K 0.04%
3,063
COP icon
174
ConocoPhillips
COP
$140B
$317K 0.04%
3,061
-1,090
-26% -$112K
REGN icon
175
Regeneron Pharmaceuticals
REGN
$79.1B
$315K 0.04%
438

Similar funds

Howe & Rusling's Q2 2023 Portfolio in Review

As of Q2 2023, Howe & Rusling held 350 positions worth $894M, up 6.5% from $839M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Howe & Rusling's Q2 2023 filing shows 47 new, 126 increased, 110 reduced and 18 closed positions. Its largest new stake was Amphenol: 172,144 shares worth $7.31M. The largest sale was Oneok, an estimated $4.03M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Howe & Rusling's largest Q2 2023 buy was Amphenol: 172,144 shares worth $7.31M.
  • Howe & Rusling added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $3.04M increase.
  • Howe & Rusling's biggest Q2 2023 reduction was Oneok, cutting an estimated $4.03M.
  • Howe & Rusling fully exited Charter Communications in Q2 2023, selling an estimated $494K.
  • Howe & Rusling's ten largest holdings make up 28% of its $894M portfolio in Q2 2023.
  • Howe & Rusling opened 47 new positions and closed 18 in Q2 2023.
  • Howe & Rusling's portfolio value rose 6.5% quarter-over-quarter to $894M.

Based on Howe & Rusling's 13F filing for Q2 2023, filed 14 Aug 2023.